These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23770542)

  • 1. In vitro selective inhibitory effect of 8-hydroxyquinoline against bifidobacteria and clostridia.
    Novakova J; Vlkova E; Bonusova B; Rada V; Kokoska L
    Anaerobe; 2013 Aug; 22():134-6. PubMed ID: 23770542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticlostridial agent 8-hydroxyquinoline improves the isolation of faecal bifidobacteria on modified Wilkins-Chalgren agar with mupirocin.
    Novakova J; Vlkova E; Salmonova H; Pechar R; Rada V; Kokoska L
    Lett Appl Microbiol; 2016 Apr; 62(4):330-5. PubMed ID: 26849418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Selective Growth-Inhibitory Effect of 8-Hydroxyquinoline on Clostridium perfringens versus Bifidobacteria in a Medium Containing Chicken Ileal Digesta.
    Skrivanova E; Van Immerseel F; Hovorkova P; Kokoska L
    PLoS One; 2016; 11(12):e0167638. PubMed ID: 27936245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective growth-inhibitory effect of 8-hydroxyquinoline towards Clostridium difficile and Bifidobacterium longum subsp. longum in co-culture analysed by flow cytometry.
    Novakova J; Džunková M; Musilova S; Vlkova E; Kokoska L; Moya A; D'Auria G
    J Med Microbiol; 2014 Dec; 63(Pt 12):1663-1669. PubMed ID: 25298160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective growth inhibitory effect of biochanin A against intestinal tract colonizing bacteria.
    Sklenickova O; Flesar J; Kokoska L; Vlkova E; Halamova K; Malik J
    Molecules; 2010 Mar; 15(3):1270-9. PubMed ID: 20335979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of infant faecal bifidobacteria and clostridia on prebiotic oligosaccharides in in vitro conditions.
    Rada V; Nevoral J; Trojanová I; Tománková E; Smehilová M; Killer J
    Anaerobe; 2008 Oct; 14(4):205-8. PubMed ID: 18583163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria.
    Butel MJ; Roland N; Hibert A; Popot F; Favre A; Tessedre AC; Bensaada M; Rimbault A; Szylit O
    J Med Microbiol; 1998 May; 47(5):391-9. PubMed ID: 9879939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rate of isolation of "C. difficile" from stools of hospitalized patients: susceptibility of 75 strains (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131B(1):11-20. PubMed ID: 7458111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
    Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L
    Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of bifidobacteria.
    Moubareck C; Gavini F; Vaugien L; Butel MJ; Doucet-Populaire F
    J Antimicrob Chemother; 2005 Jan; 55(1):38-44. PubMed ID: 15574479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-inhibiting activities of phenethyl isothiocyanate and its derivatives against intestinal bacteria.
    Kim MG; Lee HS
    J Food Sci; 2009 Oct; 74(8):M467-71. PubMed ID: 19799675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clostridium difficile and its cytotoxin in stools of hospitalized infants. Effects of antibiotic treatment].
    Collignon A; Cotte-Laffitte J; Quero AM; Torlotin JC
    Ann Pediatr (Paris); 1987 Jun; 34(6):463-8. PubMed ID: 3619318
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth of bifidobacteria and clostridia on human and cow milk saccharides.
    Rockova S; Rada V; Marsik P; Vlkova E; Bunesova V; Sklenar J; Splichal I
    Anaerobe; 2011 Oct; 17(5):223-5. PubMed ID: 21839845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces.
    Lee YJ; Yu WK; Heo TR
    Int J Antimicrob Agents; 2003 Apr; 21(4):340-6. PubMed ID: 12672580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.
    Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
    J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans.
    Flórez AB; Ammor MS; Alvarez-Martín P; Margolles A; Mayo B
    Appl Environ Microbiol; 2006 Nov; 72(11):7377-9. PubMed ID: 16936047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective enumeration medium for bifidobacteria in fermented dairy products.
    Lim KS; Huh CS; Baek YJ; Kim HU
    J Dairy Sci; 1995 Oct; 78(10):2108-12. PubMed ID: 8598396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colitis caused by Clostridium difficile: a review.
    Weymann LH
    Am J Med Technol; 1982 Nov; 48(11):927-34. PubMed ID: 6758571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria.
    Palaria A; Johnson-Kanda I; O'Sullivan DJ
    Appl Environ Microbiol; 2012 Feb; 78(4):933-40. PubMed ID: 22101054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the composition of the intestinal microbiota in early infancy.
    Penders J; Thijs C; Vink C; Stelma FF; Snijders B; Kummeling I; van den Brandt PA; Stobberingh EE
    Pediatrics; 2006 Aug; 118(2):511-21. PubMed ID: 16882802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.